We provide stem cell-derived human respiratory cells to users who wish to utilize them in drug discovery assays and toxicity safety studies. We also offer customized differentiation of iPS cells into respiratory epithelial cells on a per-contract basis.
We have succeeded in efficiently generating human respiratory cells -which had long been known to be difficult to culture- from human stem cells. We will apply this technology and integrate it into a product/servicing package suitable for drug discovery assays and toxicity safety testing, for clients such as pharmaceutical companies, chemical companies, research institutes. Currently, we offer contract production of respiratory epithelial cells and optimization of differentiation induction methods to meet the needs of users.
If you are interested, please contact us.